ReferenceLongevity & mitochondrial research
NMN
nicotinamide mononucleotide · β-NMN · beta-nicotinamide mononucleotide
Direct NAD+ precursor studied in longevity and metabolic research.
About NMN
NMN (nicotinamide mononucleotide) is a direct biosynthetic precursor of NAD+ studied in longevity, metabolic and mitochondrial research as a means of investigating NAD+ biosynthesis. TagPep is adding NMN as a research-use-only reference material.
Mechanism studied in research
Converted to NAD+ by NMN adenylyltransferases — the salvage-pathway step studied for supporting NAD+ pools in cellular-aging research.
Areas of research investigation
- NAD+ biosynthesis research
- Longevity and sirtuin studies
- Metabolic model systems
- Comparative precursor assays
Laboratory handling
Lyophilized; reconstituted with sterile or bacteriostatic water for research and refrigerated, powder frozen and light-protected.
Comparisons
NMN research FAQ
Is NMN the same as NAD+?
No — NMN is a precursor that cells convert into NAD+. They are studied together in longevity research; see our NAD+ vs NMN page.
Is NMN available now?
It is on TagPep's research roadmap. Contact us to be notified when a documented batch is released.
Research use only. NMN is supplied as a laboratory reference material for in-vitro and research applications. It is not a drug, supplement or medical product, and is not intended for human or veterinary use, consumption, or clinical application.